Pregabalin Withdrawn Phase 3 Trials for Migraine Disorders Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00447369Efficacy of Pregabalin in Migraine Prevention